Cancer-selective targeting of the NF-kappa B survival pathway with GADD45 beta/MKK7 inhibitors

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.